Skip to main content Scroll Top

News

  • Home
  • Alzheimer
  • Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Most Viewed Posts
Clear Filters
A promising new treatment for concussion and Alzheimer’s victims?
A promising new treatment for concussion and Alzheimer’s victims?
26 September 2024
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
30 November 2019
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
1 November 2022
24 October 2023

Clinical Trials on Alzheimer’s Disease (CTAD CHINA)

Read the article

Jacques Touchon (MD, PhD), University of Montpellier and Guillaume Blivet (MPH), REGEnLIFE, France.

Share this article

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.